is tirzepatide a glp 3 vs. Semaglutide: What You Should Know Tirzepatide (GLP-2) Research Peptide |

Female participants had a past-month drinking history of more than seven drinks per week, plus two or more heavy drinking incidents of four or more drinks at one time

Calcium 52, 2835

Geographical patterns also emerged from the data, with cases reported across both high-income and low- to middle-income countries

Clinical data supporting the dose increase demonstrated that patients on the higher dose achieved meaningfully greater weight reduction with some trial arms showing average body weight loss approaching 25%, closing the efficacy gap with tirzepatide that has driven a significant portion of Wegovy's market share erosion in 2025 and 2026